Treatment’s healthcare AI developed by over 40 doctors

VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Treatment.com International Inc. (CSE: TRUE), a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health has developed the most sophisticated medical AI engine to “think like a doctor”.

The Company enlisted a team of leading doctors and engineers around the world to train its AI to process information and provide insights in the same way a doctor would. Its exclusive technology was developed from the ground up by doctors, and as a result, its ability to absorb unique and complex health information and reason like a doctor to provide an accurate assessment is unparalleled.

Treatment.com, led by its Chief Medical Officer, Dr. Kevin Peterson, assembled a team of 40 doctors to build a global library of medical knowledge specifically designed to train the AI. The AI was tested by a top 10 North American medical school, and it was so effective that the university is using it to test and train future doctors.

“I have been practicing and teaching medicine for over 35 years, and I am particularly excited by the ability of our AI to perform complex medical reasoning. The software can support and empower all of us in making better health decisions,” said Dr. Peterson.

“The applications of the technology are boundless. By understanding disease in the same way that a doctor was taught, the AI provides a medical perspective that can improve consumer health decisions or support doctors in their everyday clinical decisions. By improving everyone’s access to medical knowledge, we can promote prevention, provide earlier identification of medical problems, enhance access to medical care, and support treatments that can improve the lives of billions of people.”

The first product to use this ground-breaking resource will be Treatment.com’s Cara mobile application. Providing a symptom-based assessment for consumers, Cara is designed to assess the context of a medical problem, and to collect and track personalized information that can help a consumer make better health decisions. Cara is scheduled to be released summer 2021.

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. This summer, Cara will be empowering Canadians to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

For more investor information on Treatment.com please visit https://treatment.com/investors/.

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com